Semaglutide can mitigate antipsychotic-induced metabolic dysfunction in patients with schizophrenia, prediabetes, and overweight or obesity on second-generation antipsychotics.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/semaglutide-boosts-insulin-sensitivity-schizophrenia-care-2026a10007bn?src=rss
Author :
Publish date : 2026-03-12 12:00:00
Copyright for syndicated content belongs to the linked Source.